Pınar Ataca Atilla

478 citations
20 papers · 346 indexed · h-index 8
Topics
CAR-T cell therapy research (14 papers)Immune Cell Function and Interaction (4 papers)Multiple Myeloma Research and Treatments (3 papers)

In The Last Decade

Pınar Ataca Atilla

19 papers receiving 341 citations

Peers

Pınar Ataca Atilla
Comparison fields: 5 of 39
  • Oncology 267
  • Molecular Biology 121
  • Immunology 115
  • Genetics 102
  • Biomedical Engineering 57
Replace Xiaoqian Liang with:
Xiaoqian Liang China
LaQuisa Hill United States
Jiazhen Cui China
Patrycja Wawrzyniecka United Kingdom
Peter Gambell Australia
Feiyan Mo United States
Houli Zhao China
Minnal Gupta United States
Royce Ma United States
Ruimin Hong China
Pınar Ataca Atilla relative to Xiaoqian Liang China Xiaoqian Liang's profile →
Citations per field
00.5×
Xiaoqian Liang · 1×
Citations per year

Countries citing papers authored by Pınar Ataca Atilla

Since Specialization
Citations

This map shows the geographic impact of Pınar Ataca Atilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pınar Ataca Atilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pınar Ataca Atilla more than expected).

Fields of papers citing papers by Pınar Ataca Atilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pınar Ataca Atilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pınar Ataca Atilla. The network helps show where Pınar Ataca Atilla may publish in the future.

Co-authorship network of co-authors of Pınar Ataca Atilla

This figure shows the co-authorship network connecting the top 25 collaborators of Pınar Ataca Atilla. A scholar is included among the top collaborators of Pınar Ataca Atilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pınar Ataca Atilla. Pınar Ataca Atilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 6
3 5
4 1
5 1
6 1
7 12
8 7
9 42
10 111
11 2
12 3
13 5
14 4
15 102
16 12
17 0
18 14
19 9
20 3

About Pınar Ataca Atilla

Pınar Ataca Atilla is a scholar working on Oncology, Hematology and Immunology, having authored 20 papers that have together received 346 indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Oncology (267 citations), Immunology (115 citations) and Hematology (48 citations). Pınar Ataca Atilla has collaborated with scholars based in United States, Türkiye and South Africa. Frequent co-authors include Erden Atilla, Malcolm K. Brenner, Maksim Mamonkin, Madhuwanti Srinivasan, Feiyan Mo, Diogo Gomes‐Silva, Mary K. McKenna, Haruko Tashiro, Norihiro Watanabe and Helen E. Heslop. Their work appears in journals such as Blood, Nature Biotechnology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026